OTCMKTS:BGMD BG Medicine (BGMD) Stock Price, News & Analysis → Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad) Free BGMD Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsShort InterestStock AnalysisChartFinancialsShort Interest Get BG Medicine alerts: Email Address Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… About BG Medicine Stock (OTCMKTS:BGMD)BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.Read More Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… BGMD Stock News HeadlinesApril 6, 2024 | forbes.comModernizing MedicineFebruary 28, 2024 | benzinga.comBG Medicine Stock (OTC:BGMD), Insider Trading ActivityJuly 22, 2023 | bbc.co.ukMedicine Through TimeJune 7, 2023 | finance.yahoo.comBGMD - BG Medicine, Inc.April 22, 2023 | forbes.comJiangsu Hengrui MedicineFebruary 15, 2023 | thestreet.comWhy BG Medicine (BGMD) Stock Is Plunging TodayDecember 31, 2022 | thestreet.comWhy BG Medicine (BGMD) Is Up TodaySeptember 3, 2022 | seekingalpha.comBGMD BG Medicine, Inc.August 15, 2021 | nasdaq.comBG Medicine Inc (BGMD)August 11, 2021 | barrons.comBG Medicine Inc.See More Headlines Receive BGMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BG Medicine and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/17/2015Today6/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostic substances Sub-IndustryLife Sciences Tools & Services Current SymbolOTCMKTS:BGMD Previous SymbolNASDAQ:BGMD CUSIP08861T10 CIK1407038 Webwww.bg-medicine.com Phone(508) 549-5710Fax781-895-1119Employees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Paul R. Sohmer (Age 75)CEO, President & Director Comp: $429.17kMr. Stephen P. Hall (Age 73)CFO, Executive VP & Treasurer Comp: $351.03kDr. Aram Adourian Ph.D. (Age 54)Chief Scientific Officer Comp: $275kKey CompetitorsThermo Fisher ScientificNYSE:TMOAgilent TechnologiesNYSE:AMettler-Toledo InternationalNYSE:MTDIlluminaNASDAQ:ILMNWatersNYSE:WATView All Competitors BGMD Stock Analysis - Frequently Asked Questions How were BG Medicine's earnings last quarter? BG Medicine, Inc. (OTCMKTS:BGMD) posted its quarterly earnings results on Tuesday, November, 17th. The medical research company reported ($0.27) EPS for the quarter. The medical research company had revenue of $334 million for the quarter, compared to the consensus estimate of $695 million. What other stocks do shareholders of BG Medicine own? Based on aggregate information from My MarketBeat watchlists, some companies that other BG Medicine investors own include Aeterna Zentaris (AEZS), Glu Mobile (GLUU), Blue Ridge Mountain Resources (MHRCQ), ARCA biopharma (ABIO), Athersys (ATHX), Catalyst Pharmaceuticals (CPRX), InterCloud Systems (ICLD), Inovio Pharmaceuticals (INO), LightPath Technologies (LPTH). How do I buy shares of BG Medicine? Shares of BGMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BGMD) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BG Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BG Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.